Table 1.
Characteristics of the Study Participants (N = 38).
| Variable | |
|---|---|
| Age, median (SE), years | 66.05 (8.55) |
| Gender, men/women | 22/16 |
| Anthropomorphic measurements (SD) | |
| Weight, median (SD), kg | 69.62 (14.13) |
| Abdominal girth, median (SD), cm | 99.01 (12.12) |
| BMI, median (SD), kg/m2 | 26.48 (4.86) |
| Duration of diabetes, median (SD), years | 14.76 (8.98) |
| De novo diabetes mellitus, n (%) | 2 (5.26) |
| Laboratory measurements | |
| Glucose on admission, median (SD), mg/dl | 251.68 (146.63) |
| HBA1c, median (SD), % | 9.26 (2.62) |
| Creatinine, median (SD), mg/dl | 1.19 (0.44) |
| Comorbidities, n (%) | |
| None | 6 (15.79) |
| HTN | 26 (68.42) |
| Coronary disease | 11 (28.95) |
| COPD | 5 (13.16) |
| Renal disease | 14 (36.84) |
| Dislipidemia | 7 (18.42) |
| Ambulatory treatment, n (%) | |
| Metformine | 18 (47) |
| Sulphonylurea | 13 (34) |
| Gliptins | 2 (5) |
| Insulin (NPH) | 14 (37) |
| Insulin (crystalline) | 15 (39) |
| Insulin (glargine) | 7 (18) |
| Indication for hospitalization, n (%) | |
| Hyperglycemia | 7 (18.5) |
| Coronary disease | 10 (26.32) |
| Infection | 14 (36.84) |
| Other | 9 (23.68) |
| Outcomes of hospitalization | |
| Hospital stay, median (SD), days | 15.36 (9.77) |
| Hospital death, n (%) | 2 (5) |
BMI, body mass index; COPD, chronic obstructive pulmonary disease; HBA1c, glycosylated hemoglobin; HTN, hypertension; kg/m2, kilogram per square meter; mg/dl, milligrams per dl; NPH, Neutral Protamine Hagedorn; SD, standard deviation.